Skip to main content

Anna Rosell Novel

Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.

Institutions of which they are part

Head of group
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Rosell Novel

Institutions of which they are part

Head of group
Neurovascular Diseases
Vall Hebron Institut de Recerca

Graduated in Biology (2001) and PhD in Medicine (2005), both at Universitat Autònoma de Barcelona. My scientific education and expertise has been focused in the translational study of stroke disease and therapies. I obtained a Miguel Servet research position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and Head of the Neurovascular Research Laboratory.

As a PhD student at Vall d’Hebron Research Institute (VHIR) I was trained in the biomarkers field and clinical stroke studies, which gave me a solid understanding of the disease from a clinical perspective. After I moved to the United States for a Postdoctoral position at the Massachusetts General Hospital in a world-leading laboratory recognized for their experimental studies in cerebral ischemia (Neuroprotection Research Laboratory-MGH), which offered me the opportunity to extend my experience at a more basic and experimental level. I obtained a Miguel Servet position in 2010 from the Spanish National Institute of Health and Research Agency (Instituto Carlos III), and since February 2016 I hold a Tenure position at VHIR as Principal Investigator and since 2017 I am the head of the Neurovascular Research Laboratory. The main focus of my research is the search of new therapies for stroke patients based on neurorepair strategies with specific emphasis on the role of angio-vasculogenesis using nanomedicine and cell-therapy approaches for regenerative medicine. This has allowed me to obtain independent funding as PI from national agencies, Euronanomed program and private foundations, to supervise and guide PhD Students, Post-doctoral researchers, and establish national and International collaborations with other PIs in the neuroscience, regenerative medicine and nanotechnology fields. I do have the research accreditation of Associate Professor from AQU. My group has a distinction of Consolidated Research Group by AGAUR (2017SGR 1427) and belongs to the Spanish Cooperative Network for Research in Cerebrovascular Diseases (RICORS-2022).

Projects

ADQUISICIÓN DE UN MICROSCOPIO CONFOCAL ESPECTRAL DE RASTREO DE ALTA RESOLUCIÓN DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UNIDAD DE ALTA TECNOLOGÍA (UAT)

IP: Inmaculada Fuentes Camps
Collaborators: Miquel Vila Bover, Anna Meseguer Navarro, José García Arumí, Joan Gavaldà Santapau, Miguel Segura Ginard, Maria Nieves Martell Pérez-Alcalde, Victor Franco Puntes, Anna Santamaria Margalef, Carmen Espejo Ruiz, María José Buzón Gómez, Javier Inserte Igual, Anna Rosell Novel, Eduardo Fidel Tizzano, Trond Aasen
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 502000
Reference: EQC2019-006247-P
Duration: 01/01/2019 - 31/12/2020

Ministerio de Ciencia

ADQUISICIÓN DE UN MICROSCOPIO MULTIDIMENSIONAL WIDEFIELD EQUIPADO PARA REALIZAR EXPERIMENTOS IN VIVO, DESTINADO A LA PLATAFORMA DE MICROSCOPÍA DE LA UNIDAD DE ALTA TECNOLOGÍA (UAT)

IP: Inmaculada Fuentes Camps
Collaborators: Fco Javier Santos Vicente, Gema Ariceta Iraola, Santiago Ramon y Cajal Agüeras, Marta Martínez Vicente, Anna Meseguer Navarro, Manuel Comabella Lopez, Joan Sahuquillo Barris, Miguel Segura Ginard, Simon Schwartz Navarro, Anna Rosell Novel, Meritxell Genesca Ferrer
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 177204.2
Reference: EQC2019-006309-P
Duration: 01/01/2019 - 31/12/2020

Ministerio de Ciencia

Identificación de biomarcadores y dianas terapéuticas para la neuroreparación durante la neurorehabilitación tras el ictus.

IP: Anna Rosell Novel
Collaborators: Mª Engracia Perez Mesquida, Xavier Buxo Masip, Miguel García Gabilondo, Nicolas Garcia Rodriguez
Funding agency: Instituto de Salud Carlos III
Funding: 171820
Reference: PI19/00186
Duration: 01/01/2020 - 30/06/2024

New neurovascular remodelling strategies for neurorepair after stroke: from nanomedicine to neurorehabilitation therapies

IP: Anna Rosell Novel
Collaborators: Susana Rodriguez Gonzalez
Funding agency: Centre de Medicina Reg.de Barcelona – CMRB
Funding: 10000
Reference: CMRB/PROJ-COLAB/2019/ROSELL
Duration: 24/12/2019 - 23/06/2020

Related news

For three days, the III Stroke Congress of the national RICORS-ICTUS network and a symposium focused on cerebral haemorrhage were held.

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Santos Ortega, Alba

Santos Ortega, Alba

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Cañas Perea

Xavier Cañas Perea

Director/a d'Àrea
Clinical Research Development Directorate
Read more
Ruiz Esteve, Fernando

Ruiz Esteve, Fernando

Research technician
Neurovascular Diseases
Read more
Marcos Prieto, Susana

Marcos Prieto, Susana

Research technician
Molecular Medical Imaging
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.